Instructions to Authors  by unknown
The Kaohsiung Journal of Medical Sciences (KJMS) is 
the official peer-reviewed and SCIE-indexed journal 
of Kaohsiung Medical University (KMU). It is published 
monthly by Elsevier. The Journal aims to publish orig-
inal research and review papers on all fields of medi-
cine and related disciplines that are of topical 
interest to the medical profession.
Authors are welcome to submit reviews, original 
articles, short communications, and letters to the 
editor for consideration.
The Editorial Board requires authors to be in com-
pliance with the Uniform Requirements for 
Manuscripts Submitted to Biomedical Journals 
(URMs), which are compiled by the International 
Committee of Medical Journal Editors (ICMJE); cur-
rent URMs are available at http://www.icmje.org.
These Instructions to Authors are revised periodi-
cally by the Editors as needed. Authors should consult 
a recent issue of the Journal or visit www.kjms-
online.com for the latest version of these instruc-
tions. Any manuscript not prepared according to 
these instructions will be returned immediately to 
the author(s) without review.
1. Manuscript Submission
1.1. Online Submission
Manuscripts (meaning all submission items, including 
all text, tables, artwork, cover letter, conflicts of 
interest disclosures, and any other required docu-
ments/material) must be submitted online to the 
KJMS through the Elsevier Editorial System (EES) at 
http://ees.elsevier.com/kjms. If assistance is 
required, please refer to the tutorials for authors 
and/or customer support that are available on the 
EES website; you may also contact the Editorial 
Office. Please do not post, fax or e-mail your manu-
scripts to the Editorial Office.
Editorial Office
Kaohsiung Journal of Medical Sciences (KJMS)
Kaohsiung Medical University
100 Shih-Chuan 1st Road, Kaohsiung 807, Taiwan
Tel: (+886) 7-312-1101 ext. 2111
Fax: (+886) 7-322-1107
E-mail: kjms@kmu.edu.tw
1.2. Important Information
•	 Articles should be in Microsoft Word document for-
mat and prepared in the simplest form possible. 
We will add in the correct font, font size, margins 
and so on according to the Journal’s style.
•	 You may use automatic page numbering, but do 
NOT use other kinds of automatic formatting such 
as footnotes, headers and footers.
•	 Put text, references, table headings and tables, 
and figure legends in one file.
•	 Figures must be submitted as separate picture 
files, at the correct resolution and named accord-
ing to the figure number and format, e.g., “Fig1.
tif”, “Fig2.jpg”. Please see Section 9.8. for more 
information.
1.3. Supporting Documents
The following documents must be included in your 
submission (refer also to the Checklist that follows 
these author instructions). Items (1), (2) and (3) are 
mandatory. Items (4), (5), (6) and (7) are required 
only if they are applicable to your manuscript.
(1)  Cover Letter. This must include the following 
information:
•	 title of the manuscript
•	  names (spelled out in full) of all the authors*, and 
the institutions with which they are affiliated; 
indicate all affiliations with a superscripted low-
ercase letter after the author’s name and in front 
of the matching affiliation (*the name of each 
author should be written with the family name 
last, e.g., Wan-Lin Chang)
•	  corresponding author details (name, e-mail, mail-
ing address, telephone and fax numbers)
•	  Chinese authors should provide their names, affil-
iations and contact details in both English and 
Chinese characters
•	  a statement that the material contained in the 
manuscript has not been previously published and 
is not being concurrently submitted elsewhere
•	  persons who do not fulfill the requirements to be 
listed as authors but who nevertheless contrib-
uted to the manuscript (such as those who pro-
vided writing assistance, for example) should be 
disclosed
•	  list of manuscripts that have been published, sub-
mitted, or are in press that are similar to the sub-
mission to the KJMS (and include in your submission 
copies of those similar manuscripts so that KJMS 
Editors can be assured there is no overlap)
•	  the signature of the first author or the corre-
sponding author
(2)  Authorship & Conflicts of Interest Statement. Each 
author’s contribution to the manuscript should be 
listed. Any and all potential and actual conflicts 
of interest should also be listed (see Section 2 for 
more information). Please use the KJMS Authorship 
& Conflicts of Interest Statement form that fol-
lows these author instructions and that is also pro-
vided on the Journal’s website at www.
kjms-online.com. Your signature and those of ALL 
your coauthors must be included.
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(3)  Copyright Transfer Agreement. In the event that 
your manuscript is accepted for publication in the 
KJMS, you are required to transfer all copyright 
ownership in and relating to the work to KMU. 
Please use the KJMS Copyright Transfer 
Agreement form that follows these author 
instructions and that is also provided on the 
Journal’s website at www.kjms-online.com. Your 
signature and those of ALL your coauthors must 
be included.
(4)  Ethics Statement. Articles covering the use of 
human or animal samples in research, or human 
or animal experiments must be accompanied by a 
letter of approval from the relevant review com-
mittee or authorities. See Section 3 for more 
information.
(5)  Consolidated Standards of Reporting Trials 
(CONSORT) flow chart for randomized controlled 
trials submitted for publication. See Section 4 for 
more information.
(6)  Signed Statement of Informed Consent. Articles 
where human subjects can be identified in 
descriptions, photographs or pedigrees must be 
accompanied by a signed statement of informed 
consent to publish (in print and online) the 
descriptions, photographs and pedigrees from 
each subject who can be identified. See Section 5 
for more information.
(7)  Copyright Permission. If you have reproduced or 
adapted material from other copyrighted sources, 
the letter(s) of permission from the copyright 
holder(s) to reproduce or adapt the copyrighted 
sources must be supplied. Otherwise, such mate-
rial must be removed from your manuscript. You 
may use the Permission Request and License form 
that follows these author instructions and that is 
also provided on the Journal’s website at www.
kjms-online.com in your communication with the 
copyright holder(s).
2. Disclosure of Conflicts of Interest
A conflict of interest occurs when an individual’s 
objectivity is potentially compromised by a desire for 
financial gain, prominence, professional advance-
ment or a successful outcome. KJMS Editors strive to 
ensure that what is published in the Journal is as bal-
anced, objective and evidence-based as possible. 
Since it can be difficult to distinguish between an 
actual conflict of interest and a perceived conflict of 
interest, the Journal requires authors to disclose all 
and any potential conflicts of interest.
Conflicts of interest may be financial or non-finan-
cial. Financial conflicts include financial relationships 
such as honoraria; educational grants; participation 
in speakers’ bureaus; membership, employment, con-
sultancies, stock ownership, or other equity interest; 
expert testimony or patent-licensing arrangements. 
Non-financial conflicts include personal or profes-
sional relationships, affiliations, academic competi-
tion, intellectual passion, knowledge or beliefs that 
might affect objectivity.
Please ensure that the name of each author listed 
in your manuscript appears in either Section I or 
Section II on page 2 of the KJMS Authorship & 
Conflicts of Interest Statement form (an author’s 
name cannot appear in both Section I and Section II 
of the form).
3. Ethical Approval of Studies and Informed Consent
For human or animal experimental investigations, 
appropriate institutional review board or ethics com-
mittee approval is required, and such approval 
should be stated in the methods section of the man-
uscript. For those investigators who do not have for-
mal ethics review committees, the principles 
outlined in the Declaration of Helsinki should be fol-
lowed (World Medical Association. Declaration of 
Helsinki: ethical principles for medical research 
involving human subjects. Available at: http://www.
wma.net/en/30publications/10policies/b3/17c.
pdf).
For investigation of human subjects, state explic-
itly in the methods section of the manuscript that 
informed consent was obtained from all participating 
adult subjects and from parents or legal guardians for 
minors or incapacitated adults, together with the 
manner in which informed consent was obtained 
(e.g., oral or written).
For work involving animals, the guidelines for 
their care and use that were followed should be 
stated in the methods section of the manuscript. 
For those investigators who do not have formal 
institutional guidelines relating to animal experi-
ments, the European Commission Directive 86/609/
EEC for animal experiments (available at http://
ec.europa.eu/environment/chemicals/lab_ani-
mals/legislation_en.htm) should be followed and 
the same should be stated in the methods section of 
the manuscript.
4. Reporting Clinical Trials
All randomized controlled trials submitted for publi-
cation should include a completed Consolidated 
Standards of Reporting Trials (CONSORT) flow chart 
(please go to http://www.consort-statement.org for 
more information). The KJMS has adopted the ICMJE 
proposal that requires, as a condition of considera-
tion for publication of clinical trials, registration in a 
public trials registry. Purely observational studies 
(those in which the assignment of the medical inter-
vention is not at the discretion of the investigator) 
will not require registration. Further information can 
be found at http://www.icmje.org.
5.  Identification of Patients in Descriptions, 
Photographs and Pedigrees
A signed statement of informed consent to publish (in 
print and online) patient descriptions, photographs 
and pedigrees should be obtained from all persons 
(parents or legal guardians for minors) who can be 
identified (including by the patients themselves) in 
such written descriptions, photographs or pedigrees. 
Such persons should be shown the manuscript before 
its submission. Omitting data or making data less spe-
cific to de-identify patients is acceptable, but chang-
ing any such data is not acceptable. State explicitly 
in the methods section of the manuscript that 
informed consent was obtained from all participating 
adult subjects or from parents or legal guardians for 
minors or incapacitated adults, together with the 
manner in which informed consent was obtained 
(i.e., oral or written).
6. Previous Publication or Duplicate Submission
Submitted manuscripts are considered with the 
understanding that they have not been published pre-
viously in print or electronic format (except in 
abstract or poster form) and are not under considera-
tion in totality or in part by another publication or 
electronic medium.
7. Basic Criteria
Articles should be written in English, using American 
English spelling, and meet the following basic crite-
ria: the material is original, the information is impor-
tant, the writing is clear and concise, the study 
methods are appropriate, the data are valid, and the 
conclusions are reasonable and supported by the 
data.
8. Article Categories
The categories of articles that are published in the 
Journal are listed and described below. Please select 
the category that best describes your paper. If your 
paper does not fall into any of these categories, 
please contact the Editorial Office.
8.1. Review Articles
These should aim to provide the reader with a bal-
anced overview of an important and topical subject 
in medicine, emphasizing factors such as cause, diag-
nosis, prognosis, therapy or prevention. They should 
cover aspects of a topic in which scientific consensus 
exists as well as aspects that remain controversial 
and are the subject of ongoing scientific research. All 
articles and data sources reviewed should include 
information about the specific type of study or analy-
sis, population, intervention, exposure, and tests or 
outcomes. All articles or data sources should be 
selected systematically for inclusion in the review 
and critically evaluated.
While review articles are usually submitted by invi-
tation only, unsolicited review articles will also be 
given due consideration. Typical length: 2000–3500 
words.
8.2. Original Articles
These articles typically include randomized trials, 
intervention studies, studies of screening and diag-
nostic tests, laboratory and animal studies, cohort 
studies, cost-effectiveness analyses, case-control 
studies, and surveys with high response rates, which 
represent new and significant contributions to medi-
cal science.
Section headings should be: Abstract, Introduction, 
Methods, Results, Discussion, Conflicts of Interest 
Statement (if any), Acknowledgments (if any), and 
References.
The Introduction should provide a brief background to 
the subject of the paper, explain the importance of the 
study, and state a precise study question or purpose.
The Methods section should describe the study 
design and methods (including the study setting and 
dates, patients/participants with inclusion and exclu-
sion criteria, patient samples or animal specimens 
used, the essential features of any interventions, the 
main outcome measures, the laboratory methods fol-
lowed, or data sources and how these were selected 
for the study), and state the statistical procedures 
employed in the research.
The Results section should comprise the study 
results presented in a logical sequence, supple-
mented by tables and/or figures. Take care that the 
text does not repeat data that are presented in tables 
and/or figures. Only emphasize and summarize the 
essential features of the main results.
The Discussion section should be used to emphasize 
the new and important aspects of the study, placing 
the results in context with published literature, the 
implications of the findings, and the conclusions that 
follow from the study results.
Typical length: 2000–3000 words and not more than 
40 references.
8.3. Short Communications
These reports should be concise presentations of pre-
liminary experimental results or technical aspects of 
clinical or experimental practice that are not fully 
investigated, verified or perfected but which may be 
of widespread interest or application.
Typical length: 1000–1500 words and not more than 
25 references.
8.4. Letters to the Editor
Letters are welcome in response to previously pub-
lished KJMS articles, and may also include interesting 
case reports as well as other brief technical or clini-
cal notes of general interest. Letters should have a 
title, no more than four authors, include appropriate 
references and the corresponding author’s mailing 
and e-mail addresses. Letters are edited, sometimes 
extensively, to sharpen their focus. They may be sent 
for peer review at the discretion of KJMS Editors. 
Letters are selected based on clarity, significance, 
and space.
Typical length: 500 words and not more than 5 ref-
erences (1 table or figure may be included).
9. Manuscript Preparation
Text should be typed double-spaced on white A4 (297 
 210 mm) paper, with outer margins of 2.5 cm. The 
manuscript should include a title page, abstract, key-
words, text, conflicts of interest statement (if any), 
acknowledgments (if any), references, and figures and 
tables as appropriate. Each section of the manuscript 
should begin on a new page. Pages should be num-
bered consecutively, beginning with the title page.
9.1. Title Page
The title page should contain the following informa-
tion (in order, from the top to bottom of the page):
•	 article category
•	 article title
•	  declaration of any potential financial and non-
financial conflicts of interest
•	 running title not exceeding 50 characters
•	  IMPORTANT: please do NOT include any author 
names and affiliations or corresponding author 
information on the title page (this information 
should be listed in your cover letter instead) 
because the KJMS follows a double-blind peer 
review process
9.2. Abstracts and Keywords
An unstructured abstract (i.e., in one single paragraph 
with no subheadings), of no more than 500 words in 
length, and 3–5 relevant keywords (in alphabetical 
order) are required for the following article catego-
ries: Review Articles, Original Articles, and Short 
Communications. Keywords should be taken from the 
Medical Subject Headings (MeSH) list of Index Medicus 
(http://www.nlm.nih.gov/mesh/meshhome.html).
No abstract or keywords are required for Letters to 
the Editor.
9.3. Main Text
The text for Original Articles should be organized into 
the following sections: Introduction, Methods, 
Results, Discussion, Conflicts of Interest Statement 
(if any), Acknowledgments (if any), and References. 
Each section should begin on a new page.
9.3.1. Abbreviations
Where a term/definition will be continually referred 
to, it must be written in full when it first appears in 
the text, followed by the subsequent abbreviation in 
parentheses. Thereafter, the abbreviation may be 
used. An abbreviation should not be first defined in 
any section heading; if an abbreviation has previously 
been defined in the text, then the abbreviation may 
be used in a subsequent section heading. Restrict the 
number of abbreviations to those that are absolutely 
necessary.
9.3.2. Numbers
Numbers that begin a sentence or those that are less 
than 10 should be spelled out using letters. Centuries 
and decades should be spelled out, e.g., the Eighties 
or nineteenth century. Laboratory parameters, time, 
temperature, length, area, mass, and volume should 
be expressed using digits.
9.3.3. Units
Système International (SI) units must be used, with 
the exception of blood pressure values which are to 
be reported in mmHg. Use the metric system for the 
expression of length, area, mass, and volume. 
Temperatures are to be given in degrees Celsius.
9.3.4. Names of drugs, devices and other products
Use the Recommended International Non-proprietary 
Name (rINN) for medicinal substances, unless the 
specific trade name of a drug is directly relevant to 
the discussion. Generic drug names should appear in 
lowercase letters in the text. If a specific proprietary 
drug needs to be identified, the brand name may 
appear only once in the manuscript in parentheses 
following the generic name the first time the drug is 
mentioned in the text.
For devices and other products, the specific brand 
or trade name, the manufacturer and their location 
(city, state, country) should be provided the first 
time the device or product is mentioned in the text, 
for example, “…SPSS version 11 was used (SPSS Inc., 
Chicago, IL, USA)”. Thereafter, the generic term (if 
appropriate) should be used.
9.3.5. Gene nomenclature
Current standard international nomenclature for 
genes should be adhered to. For human genes, use 
genetic notation and symbols approved by the HUGO 
Gene Nomenclature Committee (http://www.
genenames.org). You may also refer to the resources 
available on PubMed at http://www.ncbi.nlm.nih.
gov/guide/genes-expression. The Human Genome 
Variation Society has a useful site that provides guid-
ance in naming mutations at http://www.hgvs.org/
mutnomen/index.html. In your manuscript, genes 
should be typed in italic font and include the acces-
sion number.
9.3.6. Statistical requirements
Statistical analysis is essential for all research papers. 
Use correct nomenclature for statistical methods 
(e.g., two sample t test, not unpaired t test). 
Descriptive statistics should follow the scales used in 
data description. Inferential statistics are important 
for interpreting results and should be described in 
detail.
All p values should be presented to the third deci-
mal place for accuracy. The smallest p value that 
should be expressed is p < 0.001 since additional 
zeros do not convey useful information; the largest p 
value that should be expressed is p > 0.99.
9.3.7. Personal communications and unpublished 
data
These sources cannot be included in the references 
list but may be described in the text. The author(s) 
must give the full name and highest academic degree 
of the person, the date of the communication, and 
indicate whether it was in oral or written (letter, fax, 
e-mail) form. A signed statement of permission should 
be included from each person identified as a source 
of information in a personal communication or as a 
source for unpublished data.
9.4. Acknowledgments
General acknowledgments for consultations and sta-
tistical analyses should be listed concisely, including 
the names of the individuals who were directly 
involved. Consent should be obtained from those 
individuals before their names are listed in this sec-
tion. All financial and material support for the 
research, work, writing and editorial assistance from 
internal or external agencies, including commercial 
companies, should be clearly and completely identi-
fied.
9.5. References
Authors are responsible for the accuracy and complete-
ness of their references and for correct in-text citation.
9.5.1. In the main text, tables and figure legends
•	  References should be indicated by numbers in 
square brackets in line with the text, numbered 
consecutively in order of appearance, and placed 
before punctuation. [The actual authors can be 
referred to, but the reference number(s) must 
always be given.]
•	  References cited in tables or figure legends should 
be included in sequence at the point where the 
table or figure is first mentioned in the main text.
•	  Do not cite abstracts unless they are the only 
available reference to an important concept.
•	  Do not cite uncompleted work or work that has 
not yet been accepted for publication (i.e., 
“unpublished observation”, “personal communi-
cation”) as references. Also see Section 9.3.7.
9.5.2. In the references list
•	  References should be compiled at the end of the 
manuscript according to the order of citation in 
the text.
•	  References should be limited to those cited in the 
text only.
•	  Journal references should include, in order, 
authors’ surnames and initials, article title, 
abbreviated journal name, year, volume and 
inclusive page numbers.
•	  The surnames and initials of all the authors up to 
6 should be included, but when authors number 7 
or more, list the first 6 authors only followed by 
“et al”.
•	  Abbreviations for journal names should conform 
to those used in MEDLINE.
•	  If citing a website, provide the author informa-
tion, article title, website address and the date 
you accessed the information.
•	  Reference to an article that is in press must state the 
journal name and, if possible, the year and volume.
Examples of the most common reference types are 
provided below. (Please pay particular attention to 
the formatting, word capitalization, spacing and 
style.)
Standard journal article
Hsu SW, Shu K, Lee WC, Cheng YT, Chiang PH. Adrenal 
myelolipoma: A 10-year single-center experience 
and literature review. Kaohsiung J Med Sci 2012; 
28:377–82.
Journal supplement
Kaplan NM. The endothelium as prognostic factor and 
therapeutic target: What criteria should we apply? J 
Cardiovasc Pharmacol 1998;32(Suppl 3):S78–80.
Journal article not in English but with English abstract
Kawai H, Ishikawa T, Moroi J, Hanyu N, Sawada M, 
Kobayashi N, et al. Elderly patient with cerebellar 
malignant astrocytoma. No Shinkei Geka 2008;36:799–
805. [In Japanese, English abstract]
Book with edition
Bradley EL. Medical and surgical management. 2nd ed. 
Philadelphia: Saunders; 1982.
Book with editors
Letheridge S, Cannon CR, editors. Bilingual educa-
tion: Teaching English as a second language. New 
York: Praeger; 1980.
Book chapter in book with editor and edition
Greaves M, Culligan DJ. Blood and bone marrow. In: 
Underwood JCE, editor. General and systematic 
pathology. 4th ed. London: Churchill Livingstone; 
2004, p. 615–72.
Book series with editors
Wilson JG, Fraser FC, editors. Handbook of teratol-
ogy, vols. 1–4. New York: Plenum Press; 1977–1978.
Bulletin
World Health Organization. World health report 2002: 
Reducing risk, promoting healthy life. Geneva, 
Switzerland: World Health Organization; 2002.
Electronic publications
Duchin JS. Can preparedness for biological terrorism save 
us from pertussis? Arch Pediatr Adolesc Med 2004;158(2). 
Available at http://archpedi.ama-assn.org/cgi/content/
full/158/2/106. Accessed June 12, 2004.
Smeeth L, Iliffe S. Community screening for visual 
impairment in the elderly. Cochrane Database Syst Rev 
2002(2):CD001054. Doi:10.1002/14651858.CD1001054.
Thesis
Ayers AJ. Retention of resin restorations by means of 
enamel etching and by pins. MSD thesis, Indiana 
University, Indianapolis, 1971.
Website
American Association of Oral and Maxillofacial 
Surgeons. Wisdom teeth. Rosemont, IL: AAOMS, 2008. 
Available at http://www.aaoms.org/wisdom_teeth.
php. Accessed November 15, 2008.
Company/manufacturer publication/pamphlet
Eastman Kodak Company, Eastman Organic Chemicals. 
Catalog no. 49. Rochester, NY: Eastman Kodak; 1977, 
p. 2–3.
9.6. Tables
Tables should supplement, not duplicate, the text. 
They should have a concise table heading, be self-
explanatory, and numbered consecutively in the 
order of their citation in the text. Items requiring 
explanatory footnotes should be denoted using super-
scripted lowercase letters (a, b, c, etc.), with the 
footnotes arranged under the table in alphabetical 
order. Asterisks (*, **) are used only to indicate the 
probability level of tests of significance. Abbreviations 
used in the table must be defined and placed after 
the footnotes in alphabetical order. If you include a 
block of data or table from another source, whether 
published or unpublished, you must acknowledge the 
original source.
9.7. Figures
9.7.1. General guidelines
The number of figures should be restricted to the 
minimum necessary to support the textual material. 
Figures should have an informative figure legend and 
be numbered in the order of their citation in the text. 
All symbols and abbreviations should be defined in 
the figure legend in alphabetical order. Items requir-
ing explanatory footnotes should follow the same 
style as that for tables as described in Section 9.6.
Patient identification should be obscured. All let-
tering should be done professionally and should be in 
proportion to the drawing, graph or photograph. 
Photomicrographs must include an internal scale 
marker, and the legend should state the type of spec-
imen, original magnification and stain.
Figures must be submitted as separate picture 
files, at the correct resolution (see Section 9.7.2.) 
and named according to the figure number and for-
mat, e.g., “Fig1.tif”, “Fig2.jpg”.
9.7.2. Formats
Regardless of the application used, when your elec-
tronic artwork is finalized, please “save as” or con-
vert the images to one of the following formats (note 
the resolution requirements for line drawings, half-
tones, and line/halftone combinations given below):
•	 	EPS: vector drawings. Embed the font or save the 
text as “graphics”.
•	 TIFF: color or grayscale photographs (halftones)—
use a minimum of 300 dpi.
•	 TIFF:	bitmapped	line	drawings—use	a	minimum	of	
1000 dpi.
•	 TIFF:	 combination	 of	 bitmapped	 line/halftone	
(color or grayscale)—use a minimum of 600 dpi.
•	 DOC,	XLS	or	PPT:	if	your	electronic	artwork	is	cre-
ated in any of these Microsoft Office applications, 
please supply “as is”.
Please do not:
•	 Supply	 files	 that	 do	 not	 meet	 the	 resolution	
requirements detailed above;
•	 Supply	files	that	are	optimized	for	screen	use	(such	
as GIF, BMP, PICT, WPG) as the resolution is too low;
•	 Submit	graphics	 that	are	disproportionately	 large	
for the content.
A detailed guide on electronic artwork is available at 
http://www.elsevier.com/artworkinstructions. Please 
note that the cost of color illustrations will be charged 
to the author (see Section 12 for more information).
10. The Editorial and Peer Review Process
As a general rule, the receipt of a manuscript will be 
acknowledged within 2 weeks of submission, and 
authors will be provided with a manuscript reference 
number for future correspondence. If such an 
acknowledgment is not received in a reasonable 
period of time, the author should contact the Editorial 
Office.
Submissions are reviewed by the Editorial Office to 
ensure that it contains all parts. Submissions will be 
rejected if the author has not supplied all the material 
and documents as outlined in these author instructions.
Manuscripts are then forwarded to the Editor-in-
Chief, who makes an initial assessment of it. If the 
manuscript does not appear to be of sufficient merit 
or is not appropriate for the Journal, then the manu-
script will be rejected without review. Rejected man-
uscripts will not be returned to authors unless 
requested.
Manuscripts that appear meritorious and appropri-
ate for the Journal are reviewed by at least two 
Editorial Board members or expert consultants 
assigned by the Editor-in-Chief. The KJMS follows a 
double-blind peer review process. The editors and 
reviewers will not disclose any information about a 
manuscript or its review to anyone except the manu-
script’s corresponding author.
The corresponding author will usually be notified 
within 10 weeks of whether the submitted article is 
accepted for publication, rejected, or subject to 
revision before acceptance (however, do note that 
delays are sometimes unavoidable). If revisions are 
required, authors are asked to return a revised manu-
script to the Editorial Office via the EES within 30 
days. Please notify the Editorial Office in advance if 
additional time is needed or if you choose not to sub-
mit a revised manuscript.
11. Preparation for Publication
Once a manuscript has been accepted for publica-
tion, authors should submit the final version of their 
manuscript in MS Word format, with all tables/figures 
as applicable, via the EES.
Accepted manuscripts are then copyedited accord-
ing to the Journal’s style and the galley proofs in the 
form of a PDF file are sent by the Publisher to the 
corresponding author for final approval. Authors are 
responsible for all statements made in their work, 
including changes made by the copy editor.
Proofreading is solely the authors’ responsibility. 
Note that the Editorial Board reserves the right to 
make revisions to the manuscript and the Publisher 
may proceed with the publication of your article if no 
response from the author(s) is received.
12. Publication Charges and Reprints
Authors are required to pay a publication handling 
fee of US$50 (NT$1500) for all article categories 
except invited articles.
The Journal will bear the cost of publication for arti-
cles of 4 printed pages or less for Review Articles and 
Original Articles, and 2 printed pages or less for Short 
Communications and Letters to the Editor. Authors will 
be charged for the cost of additional pages at US$100 
(NT$3000) per page. While color figures will be repro-
duced on the Journal’s Website in color free of charge, 
note that authors will be charged US$67 (NT$2000) per 
illustration, figure or table that is in color.
Authors receive 50 stapled offprints of their arti-
cles free of charge, which are sent by the Editorial 
Office to the corresponding author. Additional profes-
sional reprints (which include a cover page for the 
article) may be ordered at prices based on the cost of 
production. A reprint order form can be downloaded 
from the Journal’s website at www.kjms-online.com.
13. Copyright
The KJMS is the official peer-reviewed publication of 
KMU. Manuscripts published in the KJMS become the 
permanent property of KMU. All articles published in 
the Journal are protected by copyright, which covers 
the exclusive rights to reproduce and distribute the 
article, as well as translation rights. No KJMS article, 
in part or whole, may be reproduced, stored in any 
retrieval system, or transmitted in any form or by any 
means, electronic, mechanical, by photocopying, 
recording, or otherwise, without prior written per-
mission from KMU.
